(Q85774789)

English

Breast cancer: combining bevacizumab with chemotherapy--from maintenance to second-line treatment

scientific article published on 14 October 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

title

Breast cancer: combining bevacizumab with chemotherapy--from maintenance to second-line treatment (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Alessia Errico

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

publication date

14 October 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

published in

Nature Reviews Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

page(s)

621

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

cites work

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25311354

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25311354

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRCLINONC.2014.179

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

PubMed publication ID

25311354

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25311354

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311354%20AND%20SRC:MED&resulttype=core&format=json

(Q85774789)

Breast cancer: combining bevacizumab with chemotherapy--from maintenance to second-line treatment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)